Figure 2From: Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experienceDistant PFS, all pts (n = 69); Mean 29.6 months; 95% CI: 25.5 - 33.7 months.Back to article page